化工社化工社 化学情報印刷レポート · 研究参考用
Piperidin-4-ol → 1-{3-Methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-piperidin-4-ol
関与物質
| 役割 | 名称 | HCID | 仕込み量 |
|---|---|---|---|
| 反応物 | Piperidin-4-ol | HCID 79341 | — |
| 反応物 | 2-(4-Fluoro-2-methoxy-phenyl)-5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazole | HCID 16722645 | — |
| 生成物 | 1-{3-Methoxy-4-[5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazol-2-yl]-phenyl}-piperidin-4-ol | HCID 16722695 | 79% |
反応手順
As described for example 26, 2-(4-fluoro-2-methoxy-phenyl)-5-(5-methyl-3-phenyl-isoxazol-4-yl)-[1,3,4]oxadiazole (200 mg, 0.57 mmol) was converted using 4-hydroxy-piperidine instead of thiomorpholine to the title compound (SiO2, dichloromethane:methanol=100:0 to 90:10, 197mg, 79%) which was obtained as an off-white solid. MS: m/e=433.3 [M+H]+.
情報源と証拠
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 特許番号 | US07541372B2 |
| 出典データセット | uspto-grants-2009_06 |
| ORD ID | ord-6092f59839f64060bfe530a7dd6dec20 |
| 出典メモ | uspto-grants-2009_06 |